NCT04410575 Mental Health Assessment and Prescribing by Alberta Pharmacists Status COMPLETED Phase NA
NCT04410341 The DPP-4 Inhibitor Vildagliptin as Adjunct in Major Depressive Disorder Patients Status WITHDRAWN Phase PHASE1/PHASE2
NCT04399070 The Effect of S-ketamine for Patients Undergoing Electroconvulsive Therapy (ECT) Status UNKNOWN Phase NA
NCT04392947 Treatment of Major Depressive Disorder With Bilateral Theta Burst Stimulation Status COMPLETED Phase NA
NCT04388202 Leveraging EEG for Antidepressant Prediction With Sertraline and Escitalopram Status WITHDRAWN Phase PHASE4
NCT04388189 Leveraging EEG for Antidepressant Prediction With Duloxetine and Bupropion Status WITHDRAWN Phase PHASE4
NCT04384965 Accelerated iTBS for Depressed Patients During the COVID-19 Pandemic Status COMPLETED Phase NA
NCT04366258 Transcranial Near Infrared Radiation and Cerebral Blood Flow in Depression Status COMPLETED Phase NA
NCT04364997 Study of Desvenlafaxine in Treating Major Depressive Disorder. Status COMPLETED Phase PHASE3
NCT04358900 Unobtrusive Monitoring of Affective Symptoms and Cognition Using Keyboard Dynamics (UnMASCK) Status COMPLETED Phase N/A
NCT04353921 PSIL201 Long-term Follow-up Study: Psilocybin or Niacin / Major Depressive Disorder Status TERMINATED Phase N/A
NCT04352621 Study to Assess the Effects of Intranasal Ketamine Along With rTMS for Patients With Treatment-resistant Major Depressive Disorder (TRD) Status UNKNOWN Phase PHASE4
NCT04344678 The Phosphodiesterase 5 Inhibitor Sildenafil as an Adjunct to Antidepressants in Major Depressive Disorder Patients Status WITHDRAWN Phase NA
NCT04342299 The Antidepressant Advisor (Study 3): fMRI Study to Predict Treatment Response in Patients With Depression Status COMPLETED Phase N/A
NCT04337242 Blended Care Versus Face-to-Face Therapy for Depression Status ACTIVE_NOT_RECRUITING Phase NA
NCT04328103 Mechanisms of Emotion Regulation Underlying Successful CBT in Depression Status COMPLETED Phase N/A